HAMILTON, Ontario, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed a new contract with a US Nephrology practice to use Reliq’s proprietary iUGO Care platform to monitor Chronic Kidney Disease (CKD) patients.
“It is a testament to the flexibility of our platform that it can be used to manage so many different complex chronic conditions,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We are pleased to be working with our newest client, a Nephrology Practice in Texas, to monitor Chronic Kidney Disease patients and help improve their health outcomes. Over 36 Million Americans have CKD and the majority of these patients also have either diabetes and/or hypertension, the two primary risk factors for developing Chronic Kidney Disease. Using our highly scalable iUGO Care platform, Nephrologists can help monitor medication compliance and manage patients’ co-morbidities like diabetes and high blood pressure, helping to reduce or prevent further damage to the kidneys that could lead to End Stage Renal Disease (ESRD) and the need for costly and disruptive interventions like dialysis or a kidney transplant. We will begin onboarding patients next week, and expect to have at least 5,000 kidney disease patients on the platform by the end of this calendar year, at an average revenue of $65 USD/patient/month.”
Reliq Health